Recently, the Energy Bureau of the Inner Mongolia Autonomous Region released the first batch list of independent new-type energy storage construction projects for 2026.
Recently, Valiant Pharmaceutical’s first active pharmaceutical ingredient (API), olmesartan medoxomil, successfully passed the rigorous review of the European Directorate for the Quality of Medicines and HealthCare (EDQM) and obtained the Certificate of Suitability to the European Pharmacopoeia (CEP), supported by its advanced and independently developed research and production process.
On March 12, Liao Jiasheng, Chairman of CECEP, met with Zeng Yuqun, Chairman and CEO of CATL, and his delegation at CECEP headquarters.
On December 24, Cao Huabin, Deputy General Manager of CECEP, chaired an overseas business symposium at CGC, where participants exchanged views on the preparation of the Group’s overseas business plan for the 15th Five-Year Plan period and on advancing overseas operations.
Recently, the 19th Listed Company Value Forum and the 2025 New Quality Productive Forces Tour, hosted by Securities Times under People’s Daily, was held in Yibin, Sichuan, where the list of the 2025 ESG Top 100 Listed Companies was released. CECWPC earned a place on the list thanks to its outstanding practices and strong performance in environmental, social and corporate governance (ESG).
On the morning of December 23, the Group convened a special meeting of the Leading Group of CECEP Yangtze River Economic Belt Pollution Control Platform.
On December 18, CGC formally signed a contract with Madagascar’s water and electricity utility JIRAMA for the JIRAMA pipeline project.
Recently, CGM, a subsidiary of CGC, successfully won the bid for the El Qoseir iron ore exploration project in Egypt, marking the company’s first-ever project breakthrough in the Egyptian market.
第  16  /  41  页  总条数: 205
Produced By CMS 网站群内容管理系统 publishdate:2026-06-17 09:24:22